Embolic Selection and Techniques in the Management of Endoleaks, Pulmonary AVMs and Aneurysms: A Case-Based Presentation

Embolic Selection and Techniques in the Management of Endoleaks, Pulmonary AVMs and Aneurysms: A Case-Based Presentation

On-Demand Webcast


This webcast is based on live proceedings from the 2018 ISET/CIO conference.


Ripal Gandhi, MD, FSVM
Associate Clinical Professor
Florida International University,
Herbert Wertheim College of Medicine
Miami Cardiac & Vascular Institute
Miami, Florida

Professor and Radiology Fellowship Director
Interventional Radiology
University of Virginia School of Medicine
Editor in Chief, Journal of Vascular and Interventional Radiology
Charlottesville, Virginia

Brian Schirf, MD
Interventional Radiology
Riverside Radiology and Interventional Associates
Columbus, Ohio

Clifford Weiss, MD
Interventional Radiology
The Johns Hopkins University School of Medicine
Baltimore, Maryland

Intended Learners

This activity is designed is designed for interventional radiologists, surgeons, oncologists, and other healthcare professionals involved in the treatment of cancer or looking to expand into this arena.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify best possible embolic agent based on disease diagnosis and patient presentation.
  • Compare and contrast risks associated with various embolic agents.
  • Analyze patient cases that illustrate the management of endoleaks, pulmonary AVMs and aneurysms to better apply the method of selection of embolic agents in daily practice.
Activity Overview

This on-demand webcast is available with synchronized slides and video.

In order to be eligible for documentation of credit, participants must complete the pre-test, attend the full webinar, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Participants who completed the live version of this activity are not eligible to receive credit for this on-demand webcast.

Release Date: March 2, 2018
Expiration Date: March 26, 2020
Estimated time to complete: .75 hour

There is no fee associated with this activity.

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

The evaluation is accessible after the activity via a PC (Windows 7 or newer) or Mac (Mac OS 10.6 or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.


  In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.



NACCME designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This continuing nursing education activity awards .75 contact hour.

Nurse practitioners may participate in this educational activity and earn a certificate of completing as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements. 


Embolic Selection and Techniques in the Management of Endoleaks, Pulmonary AVMs and Aneurysms: A Case-Based Presentation is pending approval for 1 ARRT Category A CE credit by The Association for Medical Imaging Management, AHRA.

AHRA is an ARRT Recognized Continuing Education Evaluating Mechanism, (RCEEM). 

Planning Committee

The planning committee comprises Ripal Gandhi, MD, FSVM; Ziv J. Haskal, MD, FSIR, FAHA, FACR, FCIRSE; Brian Schirf, MD; Clifford Weiss, MD; Robert S. Dieter, MD, RVT, FACC; Susie Seaman, NP; and MaryEllen Fama, Emily Gibson, Jennifer Ilcyn, Randy Robbin, Colleen Waters, and Susan Yarbrough, NACCME.

Independent Clinical Reviewer: Robert S. Dieter, MD, RVT, FACC, Loyola University Medicine, Chicago, Illinois 

Nurse Planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Ripal Gandhi, MD, FSVM: Consultant—Bard, BTG, Gore, Medtronic, Merit, Penumbra  

Ziv Haskal, MD, FSIR, FAHA, FACR, FCIRSE: Consultant/Speaker Bureau—Medtronic, CR Bard, WL Gore, Boston Scientific, Bendit; Research support—Teclison, Sequana

Brian Schirf, MD: Consultant—Medtronic

Clifford Weiss, MD, FSIR: Consultant—BTG, Medtronic; Grant/Research Support—BTG, Merit Medical, Siemens Healthcare, NIH

Ms. Seaman: Advisory Board—Mölnlycke

Dr. Dieter, Ms. Fama, Ms. Gibson, Ms. Ilcyn, Mr. Robbin, Ms. Waters, and Ms. Yarbrough have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty have indicated that they will discuss the off-label use of non-adhesive liquid embolic agents. Brand names are included in this presentation for participant clarification purposes only. No product promotion should be inferred.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2018 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Grant Support

Supported by an educational grant from Medtronic.